Unicycive Therapeutics, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Unicycive Therapeutics, Inc. (UNCY) on November 14, 2025. The Company, an emerging growth company incorporated in Delaware, is reporting a material amendment to its existing equity financing arrangements.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, or debt figures. The primary financial metric disclosed is the increase in the aggregate offering price available under the Company's "at the market" (ATM) equity offering program.
- ATM Offering Capacity: Increased from $50,000,000 to $100,000,000.
- Agent: Guggenheim Securities, LLC.
- Security Type: Common Stock, par value $0.001 per share.
Material Changes
On November 14, 2025, the Company entered into Amendment No. 1 to its Sales Agreement dated November 13, 2024. This amendment doubles the maximum aggregate offering price of shares that may be sold through the ATM Offering from $50 million to $100 million. A supplement to the Sales Agreement Prospectus was filed with the SEC to reflect this change.
Outlook, Risks, and Management Commentary
The filing serves as a disclosure of the amendment and does not contain forward-looking guidance, management commentary on operational outlook, or specific risk factors beyond standard legal disclaimers. The Company notes that this report does not constitute an offer to sell securities in any jurisdiction where such an offer would be unlawful.
Key Facts for Investor Verification
- Verify the current number of shares outstanding and the potential dilution impact of selling up to an additional $50 million in shares under the expanded ATM program.
- Review the full text of Amendment No. 1 (Exhibit 1.1) for specific terms, commissions, or conditions attached to the increased offering capacity.
- Confirm the Company's current cash position and burn rate to assess the necessity of accessing the full $100 million capacity.
- Check recent trading volumes and price trends for UNCY to evaluate the feasibility of executing the ATM offering without significant market impact.